Treatment of amyloidogenic diseases

Details Treatment of amyloidogenic diseases Treatment of amyloidogenic diseases

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61K 31/573 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2643633

The invention provides preferred dosage ranges, maximum concentrations, average concentrations and monitoring regimes for use in treatment of Alzheimer's disease using antibodies to A.beta.. The invention also provides monitoring regimes that can assess changes in symptoms or signs of the patient following treatment.

L'invention porte sur des gammes de dosage, des concentrations maximales, des concentrations moyennes et des régimes de surveillance préférés pour une utilisation dans le traitement de la maladie d'Alzheimer à l'aide d'anticorps dirigés contre A-bêta. L'invention porte également sur les régimes de surveillance qui peuvent évaluer des changements de symptômes ou de signes d'un patient suivant un traitement.

Affiliated with

Also associated with

Rating

Treatment of amyloidogenic diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of amyloidogenic diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of amyloidogenic diseases will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1604403